Background: siRNA is a promising therapeutic modality highlighted by several US FDA approvals since 2018, with many more oligonucleotide assets in clinical development. To support siRNA discovery and
MicroRNAs (miRNAs) can be used as biomarkers for cancer and other human diseases; therefore, high-throughput and reliable miRNA-quantification methods are required to exploit these markers for diagnos
miRNA-ID: miRNA ID: microRNA name as listed in S1 Table. Assay name and catalog #: commercially available assay from Applied Biosystems. Sequence: sequence of the miRNA profiled by TaqMan assay.
Background: siRNA is a promising therapeutic modality highlighted by several US FDA approvals since 2018, with many more oligonucleotide assets in clinical development. To support siRNA discovery and
Multi-site miRNA calibration curve dataset for the singleplex no preamp RT-qPCR pipeline. Results for the miR-1 calibration curves that were generated at six sites (A-F) as described in Methods are pr